Drugs / Bricanyl
Regulatory milestones approvals, filings & regulatory actions · 3 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansions (2) | US (FDA) | BRICANYL | — | 1997-10-08 – 2007-12-07 | fda.gov ↗ |
| Approved | US (FDA) | BRICANYL | — | 1974-03-25 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT02103374 | Jan 2012 → Dec 2015 | chronic obstructive pulmonary disease | University Hospital, Tours | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00628758 Background | Dec 2005 → Sep 2008 | asthma | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bricanyl | “Bricanyl tb 2.5 mg” NCT00628758 ↗ |
| Route | Inhaled | “3 daily inhalations of Atrovent mixture to form Bricanyl or Ventolin form during 48 weeks” NCT02103374 ↗ |